Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

CVS Health : Research Institute Study Shows 11.4 Percentage Point Improvement in Medication Adherence Among Patients in Specialty Connect Pilot

share with twitter share with LinkedIn share with facebook
share via e-mail
02/10/2016 | 04:13am CEST

WOONSOCKET, R.I., Jan. 29, 2016/PRNewswire/ --New research published by the CVS Health (NYSE: CVS) Research Institute showed a significant improvement in adherence to specialty medications for patients enrolled in a pilot study evaluating Specialty Connect, CVS Health's innovative specialty prescription services program. New patients enrolled in the pilot were 17.5 percent more likely to pick up their first refill and existing specialty patients had an 11.4 percentage point improvement in adherence, as compared to a control group. The study was published in the most recent issue of the Journal of the American Pharmacists Association.

'The specialty market is growing rapidly and new high-cost specialty drugs, that were once limited to small patient populations, are now increasingly being indicated to treat many more patients,' said William Shrank, M.D., chief scientific officer and senior vice president, CVS Health. 'As new specialty medications are introduced, adherence to therapy will be particularly important to optimize the benefit of these very expensive medications. Specialty Connect, combined with evidence-based benefit design and utilization management strategies, can increase the likelihood that the most appropriate patients receive specialty medications and that, once received, they take them as prescribed.'

CVS Health piloted the Specialty Connect program in 115 CVS Pharmacy stores before launching the program nationwide. Patients enrolled in the pilot could choose to have medications delivered to their home or doctor's office or opt to pick up their specialty medications at their local CVS Pharmacy, while receiving specialized clinical support from CVS Specialty, the specialty pharmacy of CVS Health. Since the program's launch, more than 100,000 patients have been served, with more than half choosing to pick up their specialty prescriptions at retail.

Specialty medicines treat complex conditions such as rheumatoid arthritis, multiple sclerosis and hepatitis C. Many of these medications require special handling, storage and administration. In addition, many specialty drugs are only available at select specialty pharmacies to help ensure compliance with required safety and compliance protocols. As a result, patients often have difficulty with the logistics of filling a new prescription for a specialty medication, with as many as one quarter of traditional retail pharmacies unable to fill a specialty prescription without barriers and/or delays. CVS Specialty is the only specialty pharmacy that offers patients a choice of where to get their medicines, either at any CVS Pharmacy location or through mail delivery, which simplifies getting started on a specialty therapy. In addition, the Specialty Care Team provides round-the-clock support and patient care, including symptom management, claims processing and help managing comorbid conditions.

'CVS Specialty is the only specialty pharmacy that integrates rare disease management and coordinated care programs to make it easier for patients to start and stay on complex treatments,' added Alan Lotvin, M.D., president, CVS Specialty and executive vice president, CVS Health. 'Since we launched Specialty Connect across all CVS Pharmacy locations, we have seen high rates of adherence, and our specialty patients have reported extremely high satisfaction with their service.'

The CVS Health Research Institute is focused on contributing to the body of scientific knowledge related to pharmacy and health care through research collaborations with external academic institutions, participation in federally-funded research, analysis and sharing of CVS Health data sources and coordination of pilot programs and initiatives. CVS Health Research Institute findings support a continuous quality improvement environment, which encourages product innovation and development to benefit CVS Health patients, clients and their members.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,500 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health atwww.cvshealth.com.

Logo- http://photos.prnewswire.com/prnh/20140905/143585


CVS Health Corporation issued this content on 29 January 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 10 February 2016 03:12:28 UTC

Original Document: http://www.cvshealth.com/content/cvs-health-research-institute-study-shows-114-percentage-point-improvement-medication

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CVS HEALTH
01:48p CVS HEALTH : American Cancer Society, CVS Health Foundation Award CSU, Chico $20..
01:47p CVS HEALTH : University of Findlay Receives Grant to Become Tobacco-Free Campus
09/19 CVS HEALTH CORPORATION : Announces Quarterly Dividend
09/19 Walgreens gets regulatory nod for slimmed-down Rite Aid deal
09/19 CVS HEALTH : Foundation, American Cancer Society and Truth Initiative Team Up to..
09/19 CVS HEALTH : Announces Support for Critical Rebuilding Efforts Following Histori..
09/18 CVS HEALTH : Pharmacy launching health, wellness vending machines nationwide
09/16 CVS HEALTH : University of Richmond Partners With CVS Health for Safe Drug Dispo..
09/14 CVS HEALTH : Pharmacy Addressing Access, Affordability and Quality Care with Ann..
09/13 CVS HEALTH : Pharmacy to Acquire Select ProMedica Outpatient Pharmacies
More news
News from SeekingAlpha
09/19 CVS Health declares $0.50 dividend
09/19 I Was Right, There Was An Alpha Opportunity With My 15 Dividend Achievers
09/19 Premarket analyst action - healthcare new coverage
09/17 20% Annualized Returns From Big Dog's 20 Dividend Stocks
09/15 WALGREENS BOOTS ALLIANCE : A Dividend Aristocrat Held By Bill Gates
Financials ($)
Sales 2017 184 B
EBIT 2017 10 089 M
Net income 2017 5 289 M
Debt 2017 24 744 M
Yield 2017 2,37%
P/E ratio 2017 16,42
P/E ratio 2018 14,27
EV / Sales 2017 0,59x
EV / Sales 2018 0,57x
Capitalization 84 477 M
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 87,0 $
Spread / Average Target 4,7%
EPS Revisions
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH5.58%84 477